Tag: Diabetes
Henry Schein expands supplies platform with Acentus
November 20, 2024HME News Staff
MELVILLE, N.Y. - Henry Schein has signed an agreement to buy Tampa, Fla.-based Acentus, a national supplier specializing in delivering continuous glucose monitors (CGMs) with $35 million in annual revenue.
Along with its previous acquisitions of Prism Medical Products in 2021 and Shield Healthcare and Mini Pharmacy in 2023, Henry Schein now expects its home medical supply platform to have annual revenue of about $35 million.
“As the delivery of health care in the U.S. is increasingly...
AdaptHealth targets diabetes business for improvement
November 8, 2024Theresa Flaherty, Managing Editor
PLYMOUTH MEETING, Pa. – AdaptHealth CEO Suzanne Foster is doubling down on efforts to turn around the company’s struggling diabetes business, saying it was “worse” than she initially thought it was.
The product category, which makes up 17% of the AdaptHealth’s revenues, declined 11.8% during the third quarter, following a worse than expected performance during the second quarter.
“Following last quarter's results, I turned my attention to...
Insulet sees ‘robust’ Q3
November 8, 2024HME News Staff
ACTON, Mass. – Insulet reported revenue of $543.9 million for the third quarter of 2023, an increase of 25.7%. Total Omnipod revenue was $533.6 million, an increase of 26.4%; of that, U.S. Omnipod revenue was $395.6 million and international Omnipod revenue was $138 million. “We continue to achieve significant milestones and robust revenue growth," said Jim Hollingshead, president and CEO. “Omnipod 5 is the first and only automated insulin delivery system in the U.S. for both...
Insulet to mark National Diabetes Awareness month
November 6, 2024HME News Staff
ACTON, Mass. – Insulet will recognize National Diabetes Awareness Month and World Diabetes Day with a series of activities in November. The company will sponsor the American Diabetes Association’s two-day community event Nov. 22 – 23 in Boston and will exhibit at the ADA Community Day of Access, which includes free health care screenings and more. “People with diabetes must make dozens of decisions every day to manage their condition, which can be incredibly stressful, overwhelming...
In brief: Carelon buys CareBridge, 20 reps sign letter, OIG adds reviews
November 1, 2024HME News Staff
INDIANAPOLIS – Carelon, a division of Elevance Health, recently entered into an agreement to acquire CareBridge, a value-based manager of home and community-based services for chronic and complex members that will serve as the foundation for its home health business, company officials announced during a conference call to discuss its third quarter 2024 financial results.
"We're excited to continue to serve all its customers and members,” said Gail Koziara Boudreaux,...
Beta Bionics integrates with Libre 3 Plus
October 31, 2024HME News Staff
IRVINE, Calif. – Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor. The iLet Bionic Pancreas is an autonomous insulin delivery system that streamlines diabetes management and is the first insulin delivery system in the United States to connect to Abbott’s FreeStyle Libre 3 Plus sensor, whose readings every minute will help iLet calculate insulin doses. “Beta Bionics continues to move at lightning speed...
FDA says OK to leave FreeStyle Libre CGMs on for imaging
October 30, 2024HME News Staff
ABBOTT PARK, Ill. – Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT scans and MRIs. The U.S. Food and Drug Administration has cleared the removal of the imaging contraindication, making Abbott’s systems the first and only patient-applied CGM sensors approved for these screenings. "For people with diabetes, especially those using insulin, removing a CGM...
Sheehan to help lead AdaptHealth’s diabetes biz
October 28, 2024HME News Staff
PLYMOUTH MEETING, Pa. – Gary Sheehan has started a new role at AdaptHealth as general manager, senior vice president, of diabetes. “I am looking forward to working with the diabetes team and across the enterprise to grow this critical product category,” he wrote in a post on LinkedIn. “This is an exciting next step for me within Adapt. I am very excited about the team being assembled and our collective focus on service, growth and winning. The HME industry remains at an exciting...
CCS: ‘There’s something about that DME interaction’
September 27, 2024Theresa Flaherty, Managing Editor
DALLAS – People with diabetes fall off their therapy all the time for a variety of reasons, but DME providers are best equipped to catch them when they do, according to the results of a new study conducted by CCS.
DME patients reinitiated their use of continuous glucose monitors 22% of the time compared to 10% of pharmacy patients, the study found.
“I didn’t expect the difference to be that big,” said Dr. Arti Masturzo, chief medical officer at CCS. “People...
FTC sues PBMs
September 23, 2024HME News Staff
WASHINGTON – The Federal Trade Commission has sued the three largest prescription drug benefit managers (PBMs) – Caremark Rx, Express Scripts and OptumRx – and their affiliated group purchasing organizations for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
These practices have also impaired the ability of patients to access lower list price products and shifted the cost of high insulin list...